Literature DB >> 27172424

Animal Eye Models for Uveal Melanoma.

Jinfeng Cao1, Martine J Jager2.   

Abstract

Animal models play an important role in understanding tumor growth and may be used to develop novel therapies against human malignancies. The significance of the results from animal experiments depends on the selection of the proper model. Many attempts have been made to create appropriate animal models for uveal melanoma and its characteristic metastatic behavior. One approach is to use transgenic animal models or to implant tumor cells. A variety of tumor types have been used for this purpose: tumor cells, such as Greene melanoma, murine B16 melanoma, and human uveal melanoma cells, may be implanted in the eyes of hamsters, rats, rabbits, and mice, among others. Various inoculation routes, including into the anterior chamber and posterior compartment, and retro-orbitally, have been applied to obtain tumor growth mimicking ocular uveal melanoma. However, when we choose animal models, we must be conscious of many disadvantages, such as variable tumor growth, or the need for immunosuppression in xenogeneic grafts. In this paper, we will discuss the various eye models.

Entities:  

Keywords:  Animal models; Tumor cells; Uveal melanoma

Year:  2015        PMID: 27172424      PMCID: PMC4847684          DOI: 10.1159/000370152

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  78 in total

1.  The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma.

Authors:  Jean-Claude A Marshall; Bruno F Fernandes; Sebastian Di Cesare; Shawn C Maloney; Patrick T Logan; Emilia Antecka; Miguel N Burnier
Journal:  Carcinogenesis       Date:  2007-04-13       Impact factor: 4.944

2.  Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.

Authors:  T L Knisely; J Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-02       Impact factor: 4.799

3.  NKT cell exacerbation of liver metastases arising from melanomas transplanted into either the eyes or spleens of mice.

Authors:  Wanhua Yang; Haochuan Li; Elizabeth Mayhew; Jessamee Mellon; Peter W Chen; Jerry Y Niederkorn
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-11       Impact factor: 4.799

4.  Hamster Greene melanoma implanted in the anterior chamber of a rabbit eye: a reliable tumor model?

Authors:  T J Römer; J L van Delft; D de Wolff-Rouendaal; M J Jager
Journal:  Ophthalmic Res       Date:  1992       Impact factor: 2.892

5.  In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages.

Authors:  Long V Ly; Aabed Baghat; Mieke Versluis; Ekaterina S Jordanova; Gregorius P M Luyten; Nico van Rooijen; Thorbald van Hall; Pieter A van der Velden; Martine J Jager
Journal:  J Immunol       Date:  2010-08-16       Impact factor: 5.422

6.  Malignant melanoma in transgenic mice.

Authors:  M Bradl; A Klein-Szanto; S Porter; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

7.  Establishment of pigmented choroidal melanomas in a rabbit model.

Authors:  L K Hu; K Huh; E S Gragoudas; L H Young
Journal:  Retina       Date:  1994       Impact factor: 4.256

8.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.

Authors:  J Y Niederkorn; J Mellon; M Pidherney; E Mayhew; R Anand
Journal:  Curr Eye Res       Date:  1993-04       Impact factor: 2.424

10.  Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model.

Authors:  Daniel M Albert; Amit Kumar; Stephen A Strugnell; Soesiawati R Darjatmoko; Janice M Lokken; Mary J Lindstrom; Christine M Damico; Sarit Patel
Journal:  Arch Ophthalmol       Date:  2004-09
View more
  5 in total

1.  Histopathologic Patterns of Recurrent Choroidal Melanoma Following I-125 Plaque Brachytherapy.

Authors:  Jose J Echegaray; Thomas Plesec; Claudine Bellerive; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2019-06-18

2.  Animal Models of Uveal Melanoma.

Authors:  Ogul E Uner; Nikhila Gandrakota; Corrina P Azarcon; Hans E Grossniklaus
Journal:  Ann Eye Sci       Date:  2022-03-15

3.  The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests.

Authors:  Emi Inagaki; Eri Arai; Shin Hatou; Tomoko Sayano; Hiroko Taniguchi; Kazuno Negishi; Yae Kanai; Yasunori Sato; Hideyuki Okano; Kazuo Tsubota; Shigeto Shimmura
Journal:  Stem Cells Transl Med       Date:  2022-08-23       Impact factor: 7.655

Review 4.  Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy-From Animal Models to Clinical Trials.

Authors:  Martyna Śniegocka; Ewa Podgórska; Przemysław M Płonka; Martyna Elas; Bożena Romanowska-Dixon; Małgorzata Szczygieł; Michał A Żmijewski; Mirosława Cichorek; Anna Markiewicz; Anna A Brożyna; Andrzej T Słominski; Krystyna Urbańska
Journal:  Int J Mol Sci       Date:  2018-04-01       Impact factor: 5.923

Review 5.  Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.

Authors:  Jackson R Richards; Jae Hyuk Yoo; Donghan Shin; Shannon J Odelberg
Journal:  Pigment Cell Melanoma Res       Date:  2020-01-22       Impact factor: 4.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.